Armata Pharmaceuticals, INC Form 4 insider transactions

Director Sarah J. Schlesinger reports the acquisition of stock options in Armata Pharmaceuticals, Inc.

Director Jules Haimovitz reports acquisition of stock options in Armata Pharmaceuticals.

Director Odysseas Kostas D reports acquisition of stock options in Armata Pharmaceuticals.

Deborah Birx, CEO of Armata Pharmaceuticals, acquired 60,000 shares of common stock and 240,000 stock options on March 14, 2024.